Cargando…

Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study

Objective To examine the association between payments made by the manufacturers of pharmaceuticals to physicians and prescribing by physicians within hospital referral regions. Design Cross sectional analysis of 2013 and 2014 Open Payments and Medicare Part D prescribing data for two classes of comm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fleischman, William, Agrawal, Shantanu, King, Marissa, Venkatesh, Arjun K, Krumholz, Harlan M, McKee, Douglas, Brown, Douglas, Ross, Joseph S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989280/ https://www.ncbi.nlm.nih.gov/pubmed/27540015 http://dx.doi.org/10.1136/bmj.i4189

Ejemplares similares

Association of a Risk Evaluation and Mitigation Strategy Program With Transmucosal Fentanyl Prescribing
por: Fleischman, William, et al.
Publicado: (2019)

Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
por: Kobashi, Yurie, et al.
Publicado: (2019)

Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin
por: Hartung, Daniel M., et al.
Publicado: (2018)

Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
por: Mitchell, Aaron P, et al.
Publicado: (2022)

Correction to: Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
Publicado: (2023)

Undisclosed payments by pharmaceutical manufacturers to authors of inflammatory bowel disease guidelines in the United States
por: Al Sulais, Eman, et al.
Publicado: (2021)

Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels
por: Nusrat, Salman, et al.
Publicado: (2018)

Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs
por: Perlis, Roy H., et al.
Publicado: (2016)

Impact of the Affordable Care Act's Physician Payments Sunshine Act on branded statin prescribing
por: Li, Jing, et al.
Publicado: (2022)

Payments by US pharmaceutical and medical device manufacturers to US medical journal editors: retrospective observational study
por: Liu, Jessica J, et al.
Publicado: (2017)

Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis
por: King, Marissa, et al.
Publicado: (2013)

Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries
por: Wheelock, Kevin M., et al.
Publicado: (2021)

Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing
por: Zezza, Mark A., et al.
Publicado: (2018)

Characteristics of physicians receiving large payments from pharmaceutical companies and the accuracy of their disclosures in publications: an observational study
por: Norris, Susan L, et al.
Publicado: (2012)

Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2022)

Error in Payments From Some Pharmaceutical Companies
Publicado: (2019)

Pharmaceutical payments to Japanese certified hematologists: a retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
por: Kusumi, Eiji, et al.
Publicado: (2022)

Post-market clinical research conducted by medical device manufacturers: a cross-sectional survey
por: Ross, Joseph S, et al.
Publicado: (2015)

Pharmaceutical Payments to Authors of Dermatology Guidelines After Publication
por: Sivesind, Torunn E, et al.
Publicado: (2022)

Medicare and Medicaid Physician Payment Incentives
por: Burney, Ira L., et al.
Publicado: (1979)

Industry payments to physician journal editors
por: Wong, Victoria S. S., et al.
Publicado: (2019)

Continuous Pharmaceutical Manufacturing
por: Korhonen, Ossi
Publicado: (2020)

Pharmaceutical marketing strategies’ influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples
por: Khazzaka, Micheline
Publicado: (2019)

Performance of Temporal Artery Temperature Measurement in Ruling Out Fever: Implications for COVID-19 Screening
por: Haimovich, Adrian D., et al.
Publicado: (2020)

Analysis of payments to GI physicians in the United States: Open payments data study
por: Gangireddy, Venu Gopala Reddy, et al.
Publicado: (2020)

Female dermatology journal editors accepting pharmaceutical payments: An analysis of the Open Payments database, 2013 to 2018
por: Haque, Waqas, et al.
Publicado: (2021)

Pharmaceutical payments to Japanese board-certified dermatologists: a 4-year retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2023)

Race and Ethnicity and Emergency Department Discharge Against Medical Advice
por: Tsai, Jennifer W., et al.
Publicado: (2023)

Pharmaceutical company payments to authors of the Japanese guidelines for the management of hypertension
por: Senoo, Yuki, et al.
Publicado: (2021)

Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review
por: Spurling, Geoffrey K., et al.
Publicado: (2010)

Association of Hospital Payment Profiles With Variation in 30-Day Medicare Cost for Inpatients With Heart Failure or Pneumonia
por: Krumholz, Harlan M., et al.
Publicado: (2019)

Assessing the Economic Efficiency of Physician On-call Payments
por: Shenai, Mahesh B, et al.
Publicado: (2018)

Performance payment challenges for family physician program
por: Delgoshaei, Bahram, et al.
Publicado: (2020)

Pharmaceutical manufacturing change control /
Publicado: (1999)

The Future of Pharmaceutical Manufacturing Sciences
por: Rantanen, Jukka, et al.
Publicado: (2015)

Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2022)

Physicians payment in the United States between 2014 and 2018: An analysis of the CMS Open Payments database
por: Cuomo, Raphael E., et al.
Publicado: (2021)

Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies
por: Bhujbal, Sonal V., et al.
Publicado: (2021)

The Physician in the Making
por: McKee, T. H.
Publicado: (1904)

Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey
por: Stoll, Marlene, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uqu73mob6g91qlg01piqr6g2mi